Stephanie Willerth, PhD is Associate Professor at the University of Victoria, Canada, with dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences. She also serves as the Acting Director for the Centre for Biomedical Research, on the steering committee of the BC Regenerative Medicine Initiative, and is the Canada Research Chair in Biomedical Engineering. Within her interdisciplinary research laboratory, Dr Willerth and her team investigate how to engineer neural tissue by combining pluripotent stem cells, controlled drug delivery, and biomaterial scaffolds. Here, she discusses her newly revised chapter and how the field has progressed since the original chapter was published.
Joanne Kurtzberg, MD is a Professor of Pediatrics and Professor of Pathology at Duke University Medical School. Additionally, she is the Chief Scientific Officer and Medical Director of the Robertson Clinical and Translational Cell Therapy Program, Director of the Pediatric Blood and Marrow Transplant Program, Co-Director of the Stem Cell Laboratory, as well as Director of the Carolinas Cord Blood Bank. Dr. Kurtzberg’s research and clinical interests include using cord blood transplants for the treatment of metabolic diseases and cerebral palsy. She spoke to StemBook editor, Lisa Girard, recently about progress in these areas.
Khalid Shah heads the Molecular Neurotherapy and Imaging Laboratory at Massachusetts General Hospital where he is also Director of the Stem Cell Therapeutics and Imaging Program. In addition, he is an Associate Professor at Harvard Medical School and Harvard Stem Cell Institute Principal Faculty member. Khalid’s laboratory focuses on creating stem cell-based therapeutics for primary and metastatic brain tumors. StemBook editor, Lisa Girard, spoke with Khalid recently about recent progress in his lab.
Doug Melton is the Xander University Professor at Harvard and an Investigator of the Howard Hughes Medical Institute . He is also a co-director of Harvard's Stem Cell Institute and co-chair of the Department of Stem Cell and Regenerative Biology at Harvard. His research focused on basic developmental processes using Xenopus laveis until the diagnosis of his infant son with type 1 diabetes about 20 years ago shifted his focus toward understanding and curing the disease. Doug recently spoke with StemBook editor, Lisa Girard. Below is an edited version of that interview.
Allan Spradling is a Staff Member and Director of the Carnegie Institution Department of Embryology and an Investigator of the Howard Hughes Medical Institute. Additionally, he is an Adjunct Professor at Johns Hopkins University. Allan and his laboratory study drosophila oogenesis, and more recently the intestine, in order to explore a range of questions including differentiation, the niche, and aging. Allan recently spoke with StemBook editor, Lisa Girard.
Fiona Watt, DPhil, is Director of the Centre for Stem Cells and Regenerative Medicine at the King's College London Centre for Stem Cells and Regenerative Medicine. Additionally, she is one of the founding members of the Human Induced Pluripotent Stem Cell Initiative, and Deputy Editor of eLife. Her lab is known for its work on mammalian skin cells and uses epidermal stem cells as a model to understand stem cell-niche interactions in cell fate decisions. Fiona spoke with StemBook editor, Lisa Girard, recently and below is an edited transcript of that conversation.
Bernd Haussmann was born in Germany and studied art at the MERZ Akademie, Stuttgart Germany. His work is featured in numerous galleries and museums and he is currently the Broad Institute’s Artist in Residence. Haussmann’s abstract paintings have been said to reflect his interest in the natural world and are the means by which he seeks to understand the world and his place in it. Bernd spoke recently with StemBook editor, Lisa Girard, at the Broad Institute about his work there and the intersection of science and art.
James “Jay “ Bradner, M.D. is an Assistant Professor of Medicine at Harvard Medical School, Investigator and Staff Physician at the Dana-Farber Cancer Institute, Associate Member of the Chemical Biology Program at the Broad Institute and Affiliate Faculty member of the Harvard Stem Cell Institute. His lab is focused on chemical biological approaches to studying chromatin- associated complexes with a focus on oncology. His achievements in promoting open source drug discovery have the potential to change how cancer and disease therapies are developed. Jay spoke with the StemBook editor, Lisa Girard, about his work creating chemical tools to fight cancer, his innovative approach to distributing these tools as a means of accelerating discovery, and how this just might change how pharma thinks about making medicines.
Amar Sahay, Ph.D, is an Assistant Professor of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Center for Regenerative Medicine, and Principal Faculty at the Harvard Stem Cell Institute. His primary research interests include how plasticity mechanisms in the adult brain affect cognition and mood and how perturbations in neural circuits may contribute to psychiatric disorders. Among other honors, Dr. Sahay has been the recipient of the Society for Neuroscience Career Development Award, the NIMH Pathway to Independence Award, and the Ellison New Scholar Award. StemBook Editor, Lisa Girard, was able to talk with Dr. Sahay recently about the exciting advances in understanding how changes in neural circuitry, specifically adult hippocampal neurogenesis, affects cognition and mood.
Michael Young, Ph.D., is Associate Scientist and Director, Ocular Regenerative Medicine Institute at Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary and Associate Professor of Ophthalmology, Harvard Medical School and Affiliated Faculty member at the Harvard Stem Cell Institute...